#USA #Philadelphia #HealthVerity #RWD #peer-reviewed

Milestone Celebration of HealthVerity's 100th Publication

HealthVerity, a pioneering force in real-world data (RWD) technology and privacy-compliant data exchange, triumphantly announced the publication of its 100th peer-reviewed article. This milestone, achieved on September 10, 2025, signifies a landmark moment in the realm of healthcare research, highlighting the increasing significance of verified RWD for various medical studies. The publications based on data from HealthVerity Marketplace have covered an extensive range of healthcare issues, from cardiovascular diseases and oncology to the complexities of rare diseases and the impact of artificial intelligence (AI).

The Significance of Verified Data

The accolades received underscore the robust and stable nature of the data available from HealthVerity Marketplace, which is recognized as the nation’s largest healthcare and consumer data ecosystem. Researchers and healthcare organizations now have access to a vast array of HIPAA-compliant data types that include not only medical and pharmacy claims but also laboratory results, electronic medical records (EMR), and unstructured clinical notes. This level of access enables healthcare professionals to uncover vital insights into patient journeys, assess treatment effectiveness, and evaluate health outcomes.

Reaching the century mark in terms of scientific publications is a significant affirmation of how critical HealthVerity is for advancing real-world evidence. Leveraging RWD from HealthVerity, its partners from pharmaceutical companies to public health agencies have found the data to be reliable, innovative, and distinctly sourced—qualities that are invaluable for improving patient care and transforming clinical practices.

Versatile Applications

The publications thus far illustrate the versatility and applicability of HealthVerity's data in tackling pressing healthcare inquiries. Research teams from leading pharmaceutical and biotechnology companies have successfully utilized HealthVerity Marketplace to:

• - Track disease prevalence: Paying close attention to patient outcomes on a macro scale helps identify patterns and guide public health initiatives.
• - Analyze treatment adherence and effectiveness: Data aids in understanding how different therapies perform across various demographics and health conditions.
• - Study rare disease populations: The stability and precision of HealthVerity's data allow in-depth research on often-overlooked patient groups, which is critical for innovation in treatment.
• - Support regulatory compliance: With growing scrutiny from agencies like the FDA, having access to regulatory-grade evidence has never been more important for scientific inquiry.

In comments on the achievement, Andrew Kress, CEO of HealthVerity, remarked, "The sheer volume of published works being conducted with HealthVerity Verified data underscores not only the quality and utility of our sources but also the ease with which life sciences and public health research teams can compile essential data for their studies."

Future Directions

The potential for future research using HealthVerity’s resources appears limitless. With ongoing advancements in data integration and analytics, the landscape of healthcare research is evolving rapidly. The company is committed to continuous collaboration with researchers and institutions to amplify the use of verified RWD.

For those eager to discover the breadth of current publications based on HealthVerity's verified data, a comprehensive list is available on their official website.

In conclusion, HealthVerity's achievement in publishing 100 peer-reviewed articles not only marks a significant milestone for the company but also represents an important step forward in the broader landscape of healthcare research. As the demand for comprehensive, reliable real-world data continues to grow, organizations worldwide can trust HealthVerity to provide the necessary insights to advance science and improve patient outcomes.